Yahoo Finance January 17, 2020
Shanthi Rexaline, Benzinga

The JPMorgan Healthcare Conference, which showcases innovations in the industry and provides a platform to exchange ideas and insights as well as to make breaking announcements, went by without much fanfare this year. 

In 2019, the conference made a splash, with Bristol-Myers Squibb Co announcing its multibillion-dollar purchase of Celgene just ahead of the conference and Eli Lilly And Co revealing its intention to buy Loxo Oncology.

Deals Conspicuous By Their Absence

The 2020 conference did not see any M&A announcements outside of Teladoc Health Inc’s (NYSE: TDOC) agreement to buy enterprise telehealth solutions provider InTouch Health for $600 million. Even this deal was announced a day before the conference began. 

After a record year for M&A in 2019, biopharma acquisitions are expected to slow down a bit...